Alcobra Ltd.
(NASDAQ : ADHD)

( )
ADHD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICPTIntercept Pharmaceuticals, Inc.
-0.46%67.0622.0%$203.31m
ZGNXZogenix, Inc.
-1.17%38.1016.8%$129.47m
SHPGShire PLC Sponsored ADR
-2.08%152.050.4%$121.52m
VRXValeant Pharmaceuticals International, Inc.
-0.97%12.8014.2%$105.55m
PRGOPerrigo Co. Plc
1.78%88.596.5%$93.42m
AERIAerie Pharmaceuticals, Inc.
0.86%64.608.6%$65.80m
MNKMallinckrodt Plc
0.22%32.3517.7%$57.21m
CTLTCatalent Inc
-1.05%41.542.7%$56.23m
PTLAPortola Pharmaceuticals, Inc.
-0.73%50.507.9%$52.68m
JAZZJazz Pharmaceuticals Plc
0.00%140.502.2%$51.24m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.40%110.817.6%$49.29m
UTHRUnited Therapeutics Corporation
1.68%121.7914.4%$47.05m
ENDPEndo International Plc
0.26%7.648.9%$39.10m
SUPNSupernus Pharmaceuticals, Inc.
-0.36%41.056.4%$37.63m
MDCOMedicines Company
-0.89%34.5722.1%$36.26m

Company Profile

Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel.